MedPath

Obesity Hypoventilation Syndrome Prevalence Study

Terminated
Conditions
Obesity Hypoventilation Syndrome
Registration Number
NCT01964339
Lead Sponsor
Philips Respironics
Brief Summary

This is an observational study to characterize the prevalence of Obesity Hypoventilation Syndrome in patients referred to the sleep lab.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
44
Inclusion Criteria
  • Greater than or equal to 21 yrs. of age
  • Referred to sleep lab for diagnostic PSG, initial titration PSG or split night PSG as routine clinical care
  • BMI greater than or equal to 30kg/m2
Exclusion Criteria
  • Acutely ill or medically unstable to participate per PI
  • Current positive airway pressure(PAP therapy)users
  • Medical History of Chronic Obstructive Pulmonary Disease(COPD)
  • Incapable of providing own informed consent
  • BMI less than 30kg/m2

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Baseline venous blood drawsingle blood draw

The study involves a venipuncture and data collection at the time of sleep study. Data collection will be correlated to blood draw results.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ochsner Baptist Medical Center

🇺🇸

New Orleans, Louisiana, United States

Ochsner Baptist Medical Center
🇺🇸New Orleans, Louisiana, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.